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Background and purpose   Despite the fact that there have been 
some reports on poor performance, titanium femoral stems 
intended for cemented fixation are still used at some centers in 
Europe. In this population-based registry study, we examined 
the results of the most frequently used cemented titanium stem 
in Norway.
Patients and methods   11,876 cases implanted with the 
cemented Titan stem were identified for the period 1987–2008. 
Hybrid arthroplasties were excluded, leaving 10,108 cases for this 
study. Stem survival and the influence of age, sex, stem offset and 
size, and femoral head size were evaluated using Cox regression 
analyses. Questionnaires were sent to the hospitals to determine 
the surgical technique used.
Results   Male sex, high stem offset, and small stem size were 
found to be risk factors for stem revision, (adjusted RR = 2.5 (1.9–
3.4), 3.3 (2.3–4.8), and 2.2 (1.4–3.5), respectively). Patients oper-
ated in the period 2001–2008 had an adjusted relative risk (RR) 
of 4.7 (95% CI: 3.0–7.4) for stem revision due to aseptic stem loos-
ening compared to the period 1996–2000. Changes in broaching 
technique and cementing technique coincided with deterioration 
of the results in some hospitals.
Interpretation   The increased use of small stem sizes and 
high-offset stems could only explain the deterioration of results 
to a certain degree since the year 2000. The influence of discrete 
changes in surgical technique over time could not be fully evalu-
ated in this registry study. We suggest that this cemented titanium 
stem should be abandoned. The results of similar implants should 
be carefully evaluated. 

Femoral stems made of titanium alloys are widely used for 
total hip arthroplasty (THA), with cementless fixation. Tita-
nium stems for cemented fixation have been discredited after 
reports on early revisions due to thigh pain, cortical thicken-
ing, and femoral osteolysis. The problems have supposedly 
been caused by crevice corrosion (Willert et al. 1996). There 
have also been reports on favorable outcome of cemented tita-
nium stems (Acklin et al. 2001, Eingartner et al. 2001, Bau-
mann et al. 2007), and cemented titanium stems are still used 
at a number of centers. In Norway, a titanium femoral stem 
intended for cemented fixation has been widely used since 
1984. In a recent registry-based study of cemented THA, the 
performance of this stem (Titan) deteriorated from about the 
year 2000 (Espehaug et al. 2009). Furthermore, surgeons with 
extensive experience of the stem have contacted the regis-
try in the last few years with concerns about cases of early 
loosening. We have therefore studied the performance of this 
particular stem design in more detail in our population-based 
arthroplasty register, especially regarding implant size, offset, 
and any changes in surgical technique including cementing 
technique.
Patients and methods
The Norwegian Arthroplasty Register has collected individual 
data on primary and revision hip arthroplasty procedures since 
September 15, 1987. The register has been fully described 
and validated in earlier reports (Havelin et al. 2000, Espe-
haug et al. 2006). During the period April 1987 to January 1, 
2008, 129,481 primary THAs were reported to the register. 
11,876 primary THAs with the cemented Titan stem (DePuy, 
Leeds, UK since 1997; before that, Landanger, La Ciotat, 
France) were identified in the study period. We excluded 
hybrid arthroplasties (cemented stem and uncemented cup: 
1,768 hips) and we checked that bone cements with known 
poor results were not used in the cases included (Havelin et 
al. 1995, Espehaug et al. 2002). Thus, 10,108 hips in 8,938 
patients were included in the present study.
The Titan is a straight double-tapered Müller-type stem 
made of Ti6A14V (Figure 1). The surface is shot-blasted and 2  Acta Orthopaedica 2012; 83 (1): 1–6
analyzed retrieved Titan stems; the actual offset differences 
between lateralized and standard stems were measured on 9 
lateralized (L) and 7 standard (S) stems.
We sent a questionnaire to the 10 departments that had used 
the stem most frequently. The questionnaire included ques-
tions on surgical technique and whether the surgical tech-
nique had changed with time. Two departments were asked 
to provide radiographs that they believed to be typical for the 
revised cases.
Statistics
Kaplan-Meier survival curves were calculated, and Cox regres-
sion analyses were used to evaluate the effect of factors such 
as age, sex, time of operation (stratified into 3 periods: 1987–
1995, 1996–2000, and 2001–2008), stem offset (standard or 
lateralized), total offset, and stem size (T ≤ 11, T 12–13, T 
≥ 14). The main endpoint in the analyses was stem revision 
for aseptic stem loosening, but we also performed analyses 
with stem revision for any reason as the endpoint. Survival 
curves were stopped when less than 100 cases remained at 
risk. 270 patients were operated on bilaterally and both hips 
were included in the analyses; the effect of bilateral inclusions 
in register studies has been found to be negligible (Robertsson 
and Ranstam 2003, Lie et al. 2004).
Results
The Titan stem was used throughout the study period. Thus, 
the follow-up time ranged from 0 to 21 years. The median 
follow-up time as calculated with the reverse Kaplan-Meier 
method was 6.3 years (95% CI: 6.1–6.4) (Schemper and Smith 
1996). There was no significant difference in age and sex 
between the 3 time-period groups, whereas the proportion of 
patients with osteoarthritis as the primary diagnosis increased 
with time (chi-squared test, p < 0.001) (Table 1). Male sex had 
a relative risk (RR) of revision that was 2.5 times higher than 
that for females (for stem revision due to aseptic stem loosen-
ing) (95% CI: 1.9–3.4; p < 0.001). 
Survival of the stems that were inserted up to the year 2000 
was excellent, with regard to both aseptic stem loosening and 
stem revision for any reason. In the time period 2001–2008, 
the results were clearly poorer, and the RR in this period was 
4.7 times higher than for the period 1996–2000 (95% CI: 3.0–
7.4; p < 0.001). All numbers given from Cox analyses have 
been adjusted for age, sex, and diagnosis (Table 2 and Figure 
2). 
The failed stems typically presented with extensive osteoly-
sis with or without concomitant stem loosening (Figure 3).
Figure 1. The Titan 
cemented femoral stem.
electrochemically anodized and the 
surface roughness (Ra) is 0.8 μm. 
The stem is available in 11 sizes, and 
the 8 intermediate sizes have a later-
alized neck option. According to the 
manufacturer, the lateralization adds 
3.5 mm of femoral offset compared 
to the standard stems. The offset 
is also affected by the head/neck 
length. The CCD angle of the Titan 
stem is 44.9°; thus, n mm of added 
head/neck length yields n times cos 
44.9º mm of offset. The total offset, 
consisting of stem type (lateralized/
standard) and head/neck length, was 
calculated in each case, and the hips 
were stratified into 5 groups accord-
ing to the total offset. In a concurrent 
study (unpublished data) we have 
Table 1. Patient characteristics and femoral stem epidemiology
  1987– 1996– 2001–
  1995 2000 2008
No. of hips  2,895  2,635  4,483
No. of hospitals with 
   > 100 hips in the period  8  8  8
Patient age (median, range)  73.8  74.7  74.7
Sex (% males)  28  26  27
Diagnosis (% osteoarthritis)  70  74  78
Stem size (%)  
 T  ≤  11  29 32 39
   T = 12–13  45  48  44
   T ≥  14  26 20 17
Stem offset (% lateralized stems)  4.5  5.1  9.4
Femoral head size (%)  
  28 mm  26  95  100
   32 mm  74  5  0
Femoral head material (%)   
 Steel  80  52  0
  Cobalt  chrome  0 44 95
  Others  20 7 4
Bone cement (%) 
  Palacos  16 4 0
  Palacos with Gentamycin  79  95  61
  Refobacin  Palacos  0 0 5
  Palacos R+G  0  0  17
  Refobacin Bone Cement R  0  0  14
  Simplex  4 0 0
 Others/Missing  a  1 1 3
a Simplex-Erythromycine/Colistin, Palacos E-Flow, Simplex with 
Tobramycine, Cemex with Gentamycin, SmartSet HV, Cemex Sys-
teme Genta Fast, Optipac Refobacine Bonecement.
Table 2. Kaplan-Meier survival and Cox regression analysis with 
adjustments made for age, sex, and diagnosis. The endpoint was 
revision of the stem for aseptic loosening 
  Relative risk of  p-value  Survival at 7 
  revision (95% CI)    years (95% CI)
1987–1995  1.3 (0.8–2.1)  0.1  99.0 (98.6–99.4)
1996–2000 (ref.)  1  –  99.0 (98.6–99.5)
2001–2008  4.7 (3.0–7.4)  < 0.001  95.7 (94.6–96.8)Acta Orthopaedica  2012; 83 (1): 1–6  3
The use of stem sizes T11 or smaller, and of lateralized 
stems increased with time (chi-squared test, p < 0.001) and the 
most pronounced increase was in the latest period. Cox regres-
sion analyses indicated that the lateralized stems had an RR 
that was 3.3 (95% CI: 2.3–4.8, p < 0.001) times higher than 
for stem revision of standard stems (Table 3  and Figure 4). 
For the retrieved stems, we found a mean difference of 8.1 
mm (range 6.7–9.0) in offset between stem sizes 10 through 
14—as opposed to 3.5 mm that was stated in the product mar-
keting literature. The manufacturer later confirmed that the 
total offset between S and L stems was 7.7 mm across the 
range, and this was used for the “total offset” calculations. The 
stems with the highest total offset had 16 mm higher offset 
than the ones with the lowest offset. The risk of stem revision 
increased with increasing total offset (Table 4). 
Stems of size T11 or smaller were shown to have an RR of 
revision that was 2.2 times that for stem sizes of T14 or larger 
(RR = 2.2, CI: 1.4–3.5; p < 0.001) (Figure 5 and Table 3). The 
poorer results with the smaller stems and the lateralized stems 
were also found when looking at each time period separately. 
However, when the RR (with any stem revision as endpoint) 
was calculated with adjustments made for all the risk fac-
tors mentioned—including stem size and lateralization/total 
offset—the risk of stem revision was still 3.9 (CI: 2.5–6.3) 
Figure 2. Survival of the stem in stratified time periods. The endpoint 
was revision of the stem for aseptic loosening.
Table 3. Cox regression analysis with adjustments for time period 
and diagnosis. The impact of age, sex, neck option, femoral stem 
size, and femoral head size. The endpoint was stem revision for 
aseptic loosening
  Relative risk of  p-value
  revision (95% CI)
Age  0.9 (0.9–1.0)  < 0.001
Sex a  2.5 (1.9–3.4)  < 0.001
Neck option: standard (ref.)   1  –
  lateralized   3.3 (2.3–4.8)  < 0.00 1
Stem size:  
   ≤ 11  2.2 (1.4–3.5)  < 0.001
   12–13   1.1 (0.7–1.8)  0.7
   ≥ 14 (ref.)  1  –
Femoral head size:  
  32 mm (ref.)   1  –
  28 mm     0.9 (0.5–1.6)  0.8
a Female sex was the reference group (RR = 1).
Figure 4. Survival of the stem according to femoral offset (standard vs. 
lateralized). The endpoint was stem revision for any reason. 
Figure 3. Example of a revision case 3 years after surgery (A), and 5 
years after surgery showing extensive osteolysis (B and C). Another 
case at 2 years (D) and 6 years (E) with a similar appearance.
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times higher in the period 2001–2008 than in the period 1996–
2000. Thus, the poorer survival in the latest period was only 
partially caused by increased use of small stems and lateral-
ized stems. 
The use of 32 mm femoral heads decreased, and the use of 
28 mm heads increased from 1992 through 1998. Head size 
had no statistically significant effect on survival of the stem 
(Table 3). 
7 of 10 departments responded to the questionnaires. During 
the inclusion period, there was a change of broach design from 
sharp, “aggressive” broaches to smoother impacting broaches. 
The exact year of transition is known for only one department. 
However, the other departments estimated that the transition 
took place some time between 1996 and 2002. The company 
that supplied the broaches could not state the exact year in 
which the broaches were exchanged at the individual depart-
ments. 5 of the 7 departments reported that there had been a 
trend towards a standard cementing technique since the late 
1990s. Prior to this, the “French paradox” cementing tech-
nique (meaning that the largest stem possible was inserted with 
a thin cement mantle) was the technique preferred by most 
surgeons (Langlais et al. 2003, Skinner et al. 2003). There was 
no tendency of worse results for hospitals that changed their 
cementing technique compared to the hospitals that continued 
to use the “French paradox” technique throughout the inclu-
sion period.
Discussion
In Norway, 2 types of cemented titanium stems have been 
used since the national registry started in 1987. Until recently, 
both were among the best-performing implants in the country. 
The ITH stem (Smith and Nephew, Memphis, TN) was used 
until 2005 and had a revision rate of 4.1% at 18 years (Espe-
haug et al. 2009). The Titan stem also performed excellently 
until the year 2000. We have shown that small stem size and 
high stem offset were risk factors for revision, but these fac-
tors could only partly explain the shift from excellent results 
to poor results.
Femoral offset has been found to show a positive correla-
tion with hip stability, range of motion, and abductor muscle 
strength (McGrory et al. 1995). The negative effects of large 
offset and small stem size on prostheses survival were recently 
documented in another registry study (Thien and Karrholm 
2010). High offset not only increases the lever arm for abduc-
tion, but it also increases the mechanical strain and lever 
arm on the femoral stem in varus and retroversion. The com-
bination of small stem and high offset creates higher strain 
on a reduced implant surface area, which could lead to early 
debonding and eventually loosening (Asayama et al. 2005).
The increased use of high-offset stems and smaller stem 
sizes in the present study indicates a change in operative tech-
nique. There is no reason to believe that the alterations in stem 
size and offset were caused by any change in the patient popu-
lation. Patient age and sex were not significantly different in 
the 3 different time periods. The only difference that emerged 
was the proportion of osteoarthritis, which had increased in 
the last period. We do not, however, believe that this change 
can affect stem size and stem offset to a clinically relevant 
degree. 
Around 1999, the material of the femoral head was changed 
from stainless steel to cobalt chrome. This change of femoral 
head material coincided with the deterioration in the results. 
However, the influence of this transition could not be evalu-
ated in the present study because the 2 materials were used in 
different time periods. Cobalt chrome has been the material 
of choice for many years, and there have been no reports to 
suggest that cobalt chrome gives poorer results than stainless 
steel. Thus, it is unlikely that the transition to cobalt chrome 
heads was responsible for the poor results after 2000.
The bone cements used were the same throughout the 
study period, and they were Palacos-based cements in 97% 
of cases (Table 1). According to the manufacturers, no modi-
fications were made to these products in terms of chemical 
Table 4. The total offset (stem type and head/neck length) stratified 
into 5 groups. Relative risk (RR) of stem revision for aseptic stem 
loosening (Cox, adjusted for sex, age, stem size, and femoral head 
size)
Total offset  No. of  No. of  No. of  RR (95% CI)
  hips  standard lateralized
    stems stems
 ≤ 3 mm  2,969  2,969  0  –
3–5 mm  4,391  4,391  0  1.6 (1.1–2.5)
5–7 mm  1,411  1,411  0  1.4 (0.8–2.4)
7–9 mm  495  238  257  5.1 (3.0–8.9)
 > 9 mm  504  86  418  3.9 (2.2–6.9)
Figure 5. Survival of the stem according to stem size. The endpoint was 
stem revision for any reason.
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composition and manufacturing process during the study 
period. The Palacos bone cements sold by Biomet and 
Schering-Plough were, however, removed from the market in 
2005 and replaced by the Palacos R+G produced by Heraeus 
Medical. Since then, Biomet have produced a Palacos copy, 
the Refobacin Bone Cement. The latter two have been the 
predominant bone cements in Norway since 2005. All these 
4 variants of the Palacos bone cement were used during the 
study period. There has been some controversy regarding the 
comparability of the four, and some authors have found dif-
fering mechanical and handling properties (Dall et al. 2007, 
Bridgens et al. 2008). 
According to a recent registry study, the four cement brands 
had equal results when used with the most common cemented 
hip prostheses in Norway (Espehaug et al. 2009). Results with 
the Charnley stainless steel stem, which has been the most 
commonly used stem on a national basis since 1987, actually 
improved after the year 2000 when used with the same bone 
cements as the Titan. These findings contradict the hypoth-
esis that changes to the bone cements were responsible for the 
poorer results since 2000.
Change from manual mixing to vacuum mixing of the bone 
cement alters the physical properties of the cement (Muller 
et al. 2002). Specifically, vacuum mixing gives increased 
shrinking during curing of the cement. This could affect the 
performance of the stem. Unfortunately, we do not have infor-
mation on which mixing method was used in the individual 
cases. We do know, however, that the transition from manual 
mixing to vacuum mixing occurred in Norwegian hospitals 
during the years 1990 to 1996. Thus, it is unlikely that the 
change of mixing method affected the results of the stem in 
question.
The “French paradox” involves using the same stem size as 
the largest broach used. This technique produces a thin cement 
mantle, which is more prone to defects in the mantle. How-
ever, good results have been documented using this technique, 
and in a comparative study the “French paradox” gave out-
come that was comparable to that with a standard cementing 
technique (Skinner et al. 2003). Our register does not include 
details on the cementing technique used in individual patients. 
According to the questionnaires we sent out, the use of the 
“French paradox” technique seemed to lose ground compared 
to a standard technique over a period of time in the late 1990s. 
Thus, there was a change in surgical technique that roughly 
coincided with the deterioration in outcome. However, there 
was no difference in results between the hospitals that used the 
“French paradox” throughout the whole inclusion period and 
the hospitals that changed to a standard cementing technique. 
The effect of the change in cementing technique is therefore 
uncertain.
The broaches were modified from sharp cutting broaches 
to smoother impacting broaches during the inclusion period. 
We could not, however, find the transition time in the differ-
ent departments with any degree of accuracy. The registry 
database does not include details of surgical instrumenta-
tion. Thus, the influence of the different broaches on implant 
survival cannot be evaluated. The characteristics of the bone 
bed influence the quality of cementation, and eventually the 
clinical results. Sharp broaches remove some of the spongeous 
bone whereas smooth broaches impact this devitalised bone. 
Theoretically, intrusion of bone cement into an impacted bone 
bed would be poorer than into a more porous bone bed. This, 
in turn, could alter the quality of primary fixation. Further-
more, when bone is impacted rather than removed, stability of 
the broach may be achieved with a smaller broach thus dictat-
ing a smaller stem to be implanted. The change of broaches 
and the increased use of smaller stems coincided, but this find-
ing does not prove a causative relationship. According to the 
manufacturer of the stem, no modifications were made to the 
implant.
The information from the manufacturer on the offset differ-
ences between standard and lateralized stems was inconsis-
tent, and our findings have later been confirmed by the manu-
facturer. Inaccurate data from a manufacturer of implants for 
clinical use is of course inconvenient. 
Whether the current problems with this stem are due to 
alterations in surgical technique, instrumentation, or the char-
acteristics of bone cement cannot be determined from this 
study. The mechanical properties of titanium may mean less 
tolerance to minute changes in the surgical technique, espe-
cially the cementation, than less elastic materials such as steel 
or cobalt chromium. We are currently analyzing retrieved 
Titan stems to search for any differences in the surface or 
geometry of the stems from the last time period compared to 
earlier stems, with a view to investigating the mechanism(s) 
of failure. 
Despite the fact that there have been some positive reports 
on cemented titanium stems (Acklin et al. 2001, Baumann et 
al. 2007, Eingartner et al. 2001), our findings and the accu-
mulated negative results with these implants suggest that they 
should be abandoned.
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